Young age under 60years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Young age under 60years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer

Published:2011-12 Issue:3 Volume:101 Page:508-512
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Klayton Tracy L.,Ruth Karen,Horwitz Eric M.,Uzzo Robert G.,Kutikov Alexander,Chen David Y.T.,Sobczak Mark,Buyyounouski Mark K.

Funder

National Cancer Institute, NIH

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference41 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005;Welch;J Natl Cancer Inst,2009

3. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC–NPCR Patterns of Care Study (PoC1);Schymura;BMC Cancer,2010

4. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study;Harlan;J Natl Cancer Inst,2001

5. Biochemical disease-free survival in men younger than 60years with prostate cancer treated with external beam radiation;Rosser;J Urol,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age 70 +/– 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review;International Journal of Radiation Oncology*Biology*Physics;2023-10

2. Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer;PLOS ONE;2021-03-12

3. Race is not prognostic in unfavorable prostate cancer: an NCDB analysis;International Journal of Surgery: Oncology;2020-04-03

4. Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?;Radiation Oncology;2019-06-10

5. Long-term oncological and functional outcomes support use of low-dose-rate brachytherapy with or without external beam radiation in young men (≤60 years) with localized prostate cancer;Brachytherapy;2019-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3